[go: up one dir, main page]

MX2008001551A - Compuestos de 3-aminocarbazol, composicion farmaceutica que los contiene y metodo para la preparacion de los mismos. - Google Patents

Compuestos de 3-aminocarbazol, composicion farmaceutica que los contiene y metodo para la preparacion de los mismos.

Info

Publication number
MX2008001551A
MX2008001551A MX2008001551A MX2008001551A MX2008001551A MX 2008001551 A MX2008001551 A MX 2008001551A MX 2008001551 A MX2008001551 A MX 2008001551A MX 2008001551 A MX2008001551 A MX 2008001551A MX 2008001551 A MX2008001551 A MX 2008001551A
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
composition containing
preparation
same
aminocarbazole compounds
Prior art date
Application number
MX2008001551A
Other languages
English (en)
Inventor
Maria Alessandra Alisi
Nicola Cazzolla
Guido Furlotti
Lorenzo Polenzani
Vincenzo Russo
Giorgina Mangano
Isabella Coletta
Patrizia Dragone
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of MX2008001551A publication Critical patent/MX2008001551A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se describe un compuesto de formula (I), en donde R1, R2, R3, R4, R5, R6, X e Y tienen los significados indicados en la descripcion, y las sales farmaceuticamente aceptables del mismo. una composicion farmaceutica que contiene un compuesto de formula (I) o una sal farmaceuticamente aceptable del mismo. Un metodo para preparar el compuesto anterior de formula (I) y las sales farmaceuticamente aceptables del mismo.
MX2008001551A 2005-08-03 2006-07-25 Compuestos de 3-aminocarbazol, composicion farmaceutica que los contiene y metodo para la preparacion de los mismos. MX2008001551A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001523A ITMI20051523A1 (it) 2005-08-03 2005-08-03 Composto del 3-ammino-carbazolo composizione farmaceutica che lo contiene e metodo per prepararlo
PCT/EP2006/007393 WO2007014687A1 (en) 2005-08-03 2006-07-25 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof

Publications (1)

Publication Number Publication Date
MX2008001551A true MX2008001551A (es) 2008-04-22

Family

ID=35501077

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008001551A MX2008001551A (es) 2005-08-03 2006-07-25 Compuestos de 3-aminocarbazol, composicion farmaceutica que los contiene y metodo para la preparacion de los mismos.

Country Status (23)

Country Link
US (2) US7879900B2 (es)
EP (1) EP1910288B1 (es)
JP (1) JP5274252B2 (es)
KR (1) KR101278620B1 (es)
CN (1) CN101223139B (es)
AR (1) AR056014A1 (es)
AT (1) ATE471930T1 (es)
AU (1) AU2006275063B2 (es)
BR (1) BRPI0615158A8 (es)
CA (1) CA2609441C (es)
DE (1) DE602006015062D1 (es)
DK (1) DK1910288T3 (es)
EA (1) EA012786B1 (es)
ES (1) ES2345944T3 (es)
GE (1) GEP20104964B (es)
IL (1) IL187713A (es)
IT (1) ITMI20051523A1 (es)
MX (1) MX2008001551A (es)
PL (1) PL1910288T3 (es)
PT (1) PT1910288E (es)
SI (1) SI1910288T1 (es)
UA (1) UA93378C2 (es)
WO (1) WO2007014687A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2119705A1 (en) 2008-05-14 2009-11-18 AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. 3-Aminocarbozole compound, pharmaceutical composition containing it and preparation method therefor
GB0812185D0 (en) 2008-07-03 2008-08-13 Dow Corning Polymers modified by silanes
GB0812186D0 (en) 2008-07-03 2008-08-13 Dow Corning Modified polyolefins
US10457639B2 (en) 2008-08-15 2019-10-29 Georgetown University Fluorescent regulators of RASSF1A expression and human cancer cell proliferation
GB201000128D0 (en) 2010-01-06 2010-02-24 Dow Corning Modified polymers
GB201000121D0 (en) 2010-01-06 2010-02-17 Dow Corning Modified polyolefins
GB201000120D0 (en) 2010-01-06 2010-02-17 Dow Corning Process for forming crosslinked and branched polymers
GB201000117D0 (en) 2010-01-06 2010-02-17 Dow Corning Organopolysiloxanes containing an unsaturated group
GB201006846D0 (en) 2010-04-23 2010-06-09 Glaxo Group Ltd Novel compounds
MX2010014124A (es) * 2010-12-17 2012-06-18 Gabriel Diaz Hernandez Solución antiséptica local de amplio espectro a base de hipodorito de sodio, bicarbonato de sodio, cloramfenicol, jabón y solución salina al 0.9%.
FR2972193B1 (fr) 2011-03-04 2014-07-04 Setup Performance Polyolefines modifiees, reticulables apres transformation, et procede de fabrication desdites polyolefines
US10376672B2 (en) 2013-03-15 2019-08-13 Auris Health, Inc. Catheter insertion system and method of fabrication
US11053255B2 (en) 2015-06-22 2021-07-06 Georgetown University Synthesis of mahanine and related compounds
EP4125874A4 (en) * 2020-03-25 2024-05-01 SRI International LIPOXYGENASE INHIBITORS
CN112159345B (zh) * 2020-11-18 2023-08-25 湖北和昌新材料科技股份有限公司 N-乙基咔唑的合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940719A (en) * 1986-03-27 1990-07-10 Merck Frosst Canada, Inc. Tetrahydrocarbazole esters, pharmaceutical compositions and use
JP2002241368A (ja) * 1997-02-18 2002-08-28 Shionogi & Co Ltd 新規ベンゾラクタム誘導体およびそれを含有する医薬組成物
WO2001007409A1 (en) 1999-07-23 2001-02-01 Astrazeneca Uk Limited Carbazole derivatives and their use as neuropeptide y5 receptor ligands
US6399631B1 (en) * 1999-07-23 2002-06-04 Pfizer Inc. Carbazole neuropeptide Y5 antagonists
AU769081B2 (en) * 1999-08-26 2004-01-15 Bristol-Myers Squibb Company NPY antagonists: spiroisoquinolinone derivatives
US20040067999A1 (en) 2000-12-22 2004-04-08 Block Michael Howard Carbazole derivatives and their use as neuropeptide y5 receptor ligands
DE10125961A1 (de) * 2001-05-29 2002-12-12 Boehringer Ingelheim Int Carbazolderivate und deren Verwendung zur Herstellung einer Arzneimittelzusammensetzung zur Behandlung von im Zusammenhang mit NPY stehenden Leiden
CA2403307A1 (en) * 2001-10-23 2003-04-23 Neurogen Corporation Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives
ES2193875B2 (es) * 2002-04-09 2005-03-01 Laboratorios Del Dr. Esteve, S.A. Derivados de benzoxazinona, su preparacion y su aplicacion como medicamentos.
ITMI20050909A1 (it) 2005-05-19 2006-11-20 Acraf Uso di un benzoil derivato dal 3-ammino-carbazolo per la produzione di un farmaco per il trattamento di un disturbo associato alla produzione di prostaglandina e2-pge2-

Also Published As

Publication number Publication date
EP1910288B1 (en) 2010-06-23
UA93378C2 (ru) 2011-02-10
US20080207727A1 (en) 2008-08-28
DK1910288T3 (da) 2010-10-11
JP2009502999A (ja) 2009-01-29
CA2609441C (en) 2013-09-03
JP5274252B2 (ja) 2013-08-28
EP1910288A1 (en) 2008-04-16
ITMI20051523A1 (it) 2007-02-04
ES2345944T3 (es) 2010-10-06
US8207214B2 (en) 2012-06-26
EA012786B1 (ru) 2009-12-30
IL187713A0 (en) 2008-08-07
CN101223139B (zh) 2010-11-17
WO2007014687A1 (en) 2007-02-08
ATE471930T1 (de) 2010-07-15
CN101223139A (zh) 2008-07-16
SI1910288T1 (sl) 2010-10-29
US20110046197A1 (en) 2011-02-24
US7879900B2 (en) 2011-02-01
IL187713A (en) 2011-09-27
BRPI0615158A8 (pt) 2018-03-06
PT1910288E (pt) 2010-08-18
AU2006275063B2 (en) 2012-03-08
BRPI0615158A2 (pt) 2011-05-03
AR056014A1 (es) 2007-09-12
GEP20104964B (en) 2010-04-26
PL1910288T3 (pl) 2010-11-30
EA200800502A1 (ru) 2008-06-30
KR101278620B1 (ko) 2013-06-25
CA2609441A1 (en) 2007-02-08
KR20080040691A (ko) 2008-05-08
DE602006015062D1 (de) 2010-08-05
AU2006275063A1 (en) 2007-02-08
HK1112916A1 (en) 2008-09-19

Similar Documents

Publication Publication Date Title
WO2007048064A3 (en) Amino-pyrimidines as casein kinase ii (ck2) modulators
MY186650A (en) Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
WO2008120725A1 (ja) 新規ピロリノン誘導体およびそれを含有する医薬組成物
ZA200700765B (en) Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol
TW200833370A (en) Pharmaceutical composition containing low substituted hydroxypropylcellulose
UA84712C2 (en) N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors
GEP20104964B (en) 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof
TW200640900A (en) 1-(2h)-isoquinolone derivative
PT2049480E (pt) Derivados de 2-arilindole como inibidores da mpges-i
TW200603799A (en) Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
MY139612A (en) Benzoxazine derivatives as 5-th6 modulators and uses thereof
TW200639156A (en) New compounds
PT1831208E (pt) Sais de amónio quaternário como antagonistas de m3
GEP20104875B (en) Pyrimidine derivatives for the treatment of abnormal cell growth
TW200728298A (en) Thiophene compounds and thrombopoietin receptor activators
TW200626145A (en) Heterocyclic compounds and thrombopoietin receptor activators
TW200626581A (en) Compounds, compositions containing them, preparation thereof and uses thereof
PL1831191T3 (pl) Pochodne chromanu i ich zastosowanie jako ligandów receptorów 5-HT
TW200738697A (en) Benzimidazole derivatives as 5-HT6,5-HT24
MX2009001572A (es) Derivados de arilpiperazina y usos de los mismos.
TW200626567A (en) Benzoxazine and quinoxaline derivatives and uses
IL181666A0 (en) Indolin-2-one pyridine derivatives, preparation and therapeutic use thereof
NO20073547L (no) Nikotinacetykolinreseptorligander
TW200724538A (en) Pyrazole compounds and thrombopoietin receptor activators
IL194390A0 (en) Heterocyclic gaba alpha subtype selective receptor modulators

Legal Events

Date Code Title Description
FG Grant or registration